Company intelligence / Profile preview

GenomOncology

Cleveland, Ohio, United Statesgenomoncology.com ↗

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

GenomOncology provides a commercial software platform that enables healthcare professionals to process, analyze, and report genetic test results for cancer patients. Their solutions support clinical decision-making by integrating medical data, clinical guidelines, and computational algorithms to deliver actionable insights for diagnosis and treatment. The company’s technology is used in real-world settings to streamline workflows such as NGS result interpretation and reporting. No clinical trial results are applicable as the company does not develop therapeutics.

Therapeutic areas: Oncology
Modalities: Non-pharmacological therapy (software/data platform; not a drug developer)
Industry: Digital Health Medical Devices

Partnerships

Chronetyx Laboratories (integration of Pathology Workbench with NGS testing systems for faster genomic insights in cancer care)

Beyond the preview

Go deeper on GenomOncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GenomOncology.

Explore the full profile